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ABSTRACT 
 
The mammalian skin is a versatile organ that protects from external harm, regulates the body 
temperature, and provides the touch sensation. Its epithelium, the epidermis, forms several 
highly regenerative structures as the hair follicle (HF), the sebaceous gland (SG), and the 
interfollicular epidermis (IFE). Lineage tracing experiments in mice have demonstrated that 
several basal cell populations in the IFE and HF have the capacity to renew the epidermis 
during homeostasis, and also contribute to wound healing and cancer formation. However, 
clear insights distinguishing the different stem cell populations and defining their exact 
spatio-temporal patterns of contribution were lacking. 
Expression of Lgr5 marks stem cells located in the HF bulge and hair germ. We used lineage 
tracing of Lgr5-expressing (Lgr5+) cells in mice to investigate how wound healing affects the 
capacity of epidermal stem cells to initiate skin cancer. Induction of basal cell carcinoma 
(BCC) through activation of Hedgehog signalling in the entire basal layer confirmed that 
wounding strongly increases the incidence and severity of BCC-like lesions. Targeting the 
oncogenic mutation to Lgr5+ cells revealed that transformed HF cells are able to leave their 
natural environment and establish tumours in the IFE in response to wounding. Thus, 
wounding activates HF stem cells to expand and migrate to unaffected tissue areas, thereby 
augmenting BCC development. 
Since it was discovered that Lgr6 is another epidermal stem cell marker, we set out to explore 
the role of Lgr6+ stem cells during epidermal homeostasis. Detailed analysis of the lineage-
tracing pattern of the Lgr6+ cells populations in the isthmus, SG, and IFE disclosed that these 
resident Lgr6+ populations independently maintain their respective compartment. The mode 
of tissue renewal displayed by all three Lgr6+ cell populations was in accordance with a 
stochastic division of one type of progenitor cell. These results highlight that stochastic stem 
cell renewal is relevant in many types of rapidly proliferating epithelia. 
We further investigated the susceptibility of the different epidermal compartments harbouring 
Lgr6+ stem cells towards BCC initiation and evaluated the influence of the microenvironment 
on tumour formation. Knockout of Ptch1 in Lgr6+ cells resulted in highly accelerated BCC 
development within the HF isthmus and the touch dome niches in the IFE. The touch dome 
and the isthmus are both associated with cutaneous nerve fibres, and show several 
morphological and molecular features that are highly similar to BCC. This demonstrates that 
these two niches promote the response of the epithelial cells to the oncogenic stimulus. 
In summary, tracking the fate of Lgr5- and Lgr6-expressing epidermal stem cells during 
homeostasis, wound healing and early cancer formation shed light on the similarities and 
differences between distinct stem cell populations in the skin. The results illustrate how stem 
cell renewal is achieved, elucidate the early steps of skin cancer development, and underline 
the influence of the microenvironment on the behaviour of tissue stem cells. 
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1 INTRODUCTION 
 
1.1 THE SKIN IN HOMEOSTASIS 
 
The skin is the outer shell of the mammalian body. It protects other organs from external 
harm, such as pathogens and UV radiation, regulates the body temperature, and provides the 
touch sensation. The epithelium of the skin contains several appendages that are highly 
regenerative throughout the life of the organism, such as the hair follicle (HF), sebaceous 
gland (SG), sweat gland and nails [1]. The skin is thus an excellent model tissue to study the 
capabilities of adult mammalian stem cells during homeostatic tissue maintenance. 
Structurally, the skin is divided into three main layers: the epidermis, the dermis and the skin-
associated adipose tissue, called subcutis (Figure 1). The subcutis lies beneath the dermis and 
is composed of adipocytes and fibroblasts, and harbours larger blood vessels [2,3]. The 
dermis is a connective tissue supporting the epithelial structures and constitutes the thickest 
layer of the skin. The main cellular components of the dermis are fibroblasts, myofibroblasts, 
macrophages and other immune cells [2]. The fibroblasts form an extracellular matrix 
composed of collagen and other elastic fibres [4]. The main focus of this thesis will be on the 
topmost layer of the skin, the epidermis and its appendages. 
 
Figure 1. Overview of the 
major components of human 
and murine skin. 
The skin is composed of the 
epidermis, the underlying dermis 
and the subcuteanous layer. The 
epidermis comprises hair 
follicles, sebaceous and sweat 
glands. Nerves, blood vessels 
and muscles are found within 
the dermis. The subcutaneous 
layer consists mainly of fat cells. 
Note that sweat glands are 
lacking in murine hairy skin 
(Reprinted with permission from 
[5]) 
 
 
1.1.1 The epidermis 
The epidermis is the outer epithelial lining of the skin. The vast majority of cells within the 
epidermis are keratinocytes, with minor populations of Langerhans cells, melanocytes and 
Merkel cells [2]. Keratinocytes are named after their characteristic expression of keratin 
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intermediate filaments. Keratins always occur in heterodimers and are crucial for the rigidity 
of the epithelial cells forming the outer surface of the body [6]. Remarkably, keratin 
expression differs strongly among the epidermal keratinocyte populations, with typical 
keratin pairs being associated with cells in distinct differentiation stages or different locations 
in the epidermal structures [7]. 
The stratified epidermis consists of four layers (Figure 2) and its main function is to provide 
a barrier to water loss. The bottom layer is called basal layer and the cells residing here are 
termed basal cells. In mice, they form a single layer of cells that are tightly anchored to the 
underlying basement membrane. This anchoring, which is mainly achieved by expression of 
integrin receptors, prevents them from differentiation and keeps them in an undifferentiated 
state [8,9]. Basal cells are characteristically marked by expression of keratin 5 (K5) and K14, 
and are primarily responsible for the mitotic cell divisions in the epidermis [10]. When the 
cells start to differentiate, they move upwards into the spinous and granular layer, where they 
change their biochemical composition and form tight junctions. They express the keratins K1, 
K10 and involucrin. Eventually, the suprabasal cells will lose their nucleus and become a 
flattened keratinized layer (stratum corneum) that is continuously shed from the body. 
Typical markers of the terminally differentiated cells are loricrin and filaggrin [11]. 
 
 
Figure 2. Architecture of stratified epidermis in murine dorsal skin.  
(A) The epidermis consists of four distinct layers of keratinocytes. The basal layer contains 
undifferentiated cells attached to the basement membrane. Upon differentiation cells move upwards 
to the spinous layer. In the granular layer cells prepare for terminal differentiation, where they lose 
their nuclei and form a layer of keratinized cells, which is eventually shed from the body. (B) 
Longitudinal sections through the epidermis at the level of basal cells (left), suprabasal cells (middle) 
and keratinized cells (right). The small basal cells form a densely packed layer. The nuclei of the 
flattened suprabasal cells usually cluster together. The keratinized cells form regular hexagonal 
shapes. 
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Figure 3. The hair cycle and simplified structure of the anagen bulb. 
Throughout the lifetime of an organism, the hair follicle undergoes cycles of growth (anagen), 
regression (catagen) and rest (telogen), changing the morphology of the lower part of the hair follicle. 
Hair production takes place during the anagen phase. In mice, the old hair shaft is not shed like in 
humans but retained as a club hair. The inset illustrates the arrangement of the keratinocyte layers in 
the lower anagen bulb. Closest to the dermal papilla, which is fully engulfed by keratinocytes, occurs 
most cell proliferation. The outer root sheath consists of a single layer of basal cells, while the inner 
root sheath comprises seven layers that expand upwards, accompanying the growing hair shaft. 
 
1.1.2 The hair follicle – morphogenesis and cycling 
Hair is a distinctive feature of the mammalian body. The visible hair shaft is produced by the 
HF, which is one of the appendages that are formed by the epidermal layer, invaginating into 
the underlying dermis. The HF is the most intriguing epidermal structure to study activation 
of tissue stem cells because it constantly undergoes morphological changes in order to 
produce hair. Moreover, HF cells follow several distinct differentiation paths, allowing 
investigation of stem cell lineage specification. 
In mice, the first HFs on the dorsal skin start to develop at embryonic day 14.5 (E14.5). This 
process begins with the induction of an epithelial hair placode, a localised compaction of 
epithelial cells, in response to signals from the dermis [12]. These first inductive signals are 
believed to be activation of the Wnt/β-catenin pathway [13]. Reverse signals from the 
placode stimulate the condensation of the mesenchymal cells into the so-called dermal 
papilla. The dermal papilla acts as the major signalling centre for hair growth and stays 
closely associated with every HF [14,15]. Following signals from the dermal papilla, the 
epidermal placode then develops into the hair germ, which elongates and forms the mature 
HF. The lower part of the HF now engulfs the dermal papilla, where several concentric layers 
of keratinocytes emanate (Figure 3, inset). The outer root sheath (ORS) is the outermost 
layer, which is continuous with the basal layer of the interfollicular epidermis (IFE). Seven 
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distinct layers form the inner root sheath (IRS), which surround the developing hair shaft 
[16]. The HF in this growth phase is called anagen HF. In the lower anagen HF segment, also 
called bulb, most proliferation is done by the cells that are in closest contact with the dermal 
papilla. These cells are termed matrix cells and give rise to the different lineages of the IRS 
and hair shaft [17]. 
When the hair shaft has reached its final length, at around postnatal day 16 (P16), the HF 
starts to regress. During this phase called catagen most of the cells of the bulb undergo 
apoptosis. Between P19 and P21 the HF exists in its resting conformation, termed telogen HF 
[18]. Soon after that the lower part of the HF starts to re-grow into its anagen conformation to 
produce the next hair shaft. This sequence of regression and growth continues throughout life 
and is referred to as the hair cycle (Figure 3) [19]. An important difference between the hair 
cycle in humans and mice is that the previous hair shaft is retained in mouse dorsal skin while 
the next one is growing. The hair remains anchored in its own dormant HF, which is referred 
to as club hair. In contrast, the human hair cycle contains a fourth phase following catagen, 
which is called exogen and initiates the loss of the hair shaft [20]. Moreover, in mice, dorsal 
HFs are synchronized in their hair cycle stage until 2-3 months of age, which is advantageous 
for research to start experiments at a distinct hair cycle stage. 
 
1.1.3 Stem cell niches in the hair follicle 
The continuous supply of new cells for epidermal homeostasis and hair cycling is secured by 
epidermal stem cells. Stem cells are defined by their capacity to extensively self-renew, 
generate cells that undergo terminal differentiation, and repair the tissue upon injury. To date, 
numerous stem cell markers have been identified within almost all epidermal HF 
compartments (Figure 4). 
The bulge of the telogen HF was the first stem cell compartment discovered in the epidermis. 
A labelling that is incorporated into the cell’s DNA and is diluted out in dividing cells can be 
used to identify slowly dividing cells, which is a putative property of stem cells [21]. The 
cells located in the bulge area retain DNA labelling over long periods, thus marking them as 
the most quiescent epidermal cells [22,23]. Subsequent lineage tracing experiments revealed 
that bulge cells are able to generate all lineages of the anagen HF [23,24]. Identification of 
marker genes expressed by bulge cells, such as CD34 [25], Krt15 (K15) [26], Lgr5 [27] and 
Krt19 (K19) [28], enabled further analysis of their characteristics and stem cell potential. 
Isolation and transplantation of CD34-positive (CD34+) bulge stem cells demonstrated that 
these cells are capable of regenerating the entire epidermis including full HFs [29]. However, 
during homeostasis bulge and hair germ cells are only activated upon anagen entry and their 
contribution to the other compartments above the bulge is limited [30,31]. This implies that 
stem cells outside the bulge niche must be responsible for maintenance of the upper HF 
compartments. In the narrow segment above the bulge, called isthmus, cells expressing Plet1 
[32], Lgr6 [33] and Gli1 [34] were found to possess stem cell properties by in vivo lineage 
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tracings. The junctional zone around the opening of the SG was shown to be populated by 
Lrig1-expressing cells that give rise to cells in the infundibulum and the SG [35,36]. 
Interestingly, all HF stem cell populations that were tested in transplantation assays had the 
capacity to regenerate epidermis and HFs even though their contributions during homeostasis 
are restricted to specific compartments, which demonstrates an enormous plasticity among 
epithelial stem cells [37]. 
The questions remain how this heterogeneity of stem cell markers is established and what 
regulates the specific fate choices of stem cells in particular areas. By investigating signalling 
pathways and microenvironmental components, we are only beginning to understand the 
factors that orchestrate epidermal homeostasis. 
 
 
Figure 4. The telogen hair follicle - compartments and stem cell markers. 
(A) Hematoxylin and eosin staining of paraffin-embedded dorsal skin shows the typical morphology 
of the telogen hair follicle. IFE: interfollicular epidermis; inf: infundibulum; jz: junctional zone; sg: 
sebaceous gland; i: isthmus; b: bulge; hg: hair germ; dp: dermal papilla. (B) The hair follicle structure 
is subdivided into distinct compartments. In each compartment exist basal cell populations that 
possess stem cell properties and are defined by distinct molecular markers. 
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Figure 5. Cellular and non-
cellular interactions affecting 
hair follicle stem cells.  
In the bulge and hair germ, cells 
are influenced by dermal papilla 
fibroblasts, melanocyte precursor 
cells and the arrector pili muscle 
anchorage site. Above the bulge 
epidermal cells interact with 
sensory nerve fibres and nerve-
associated neural crest-derived 
precursor cells (NCPCs). All basal 
cells are encompassed by the 
basement membrane, which 
provides specific binding sites and 
structural support. Also immune 
cells in the dermis and epidermis, 
and mechanical forces can alter 
the fate of hair follicle stem cells. 
 
 
The Wnt and the bone morphogenic protein (Bmp) pathways are important mechanisms to 
control activation and quiescence of hair germ and bulge cells. The dermal papilla situated 
just underneath the hair germ, is a condensate of specialized mesenchymal fibroblasts and is 
essential for initiating anagen entry and hair growth [14,15]. Dermal papilla cells have been 
shown to secrete Wnt molecules and Bmp inhibitors to activate proliferation in the nearby 
hair germ cells, as the first step of hair regeneration [30]. 
Moreover, a variety of structures and cell types in the dermis have been shown to influence 
epidermal stem cells (Figure 5). The arrector pili muscle, which is responsible for erection of 
the hair, is anchored to the basal lamina of bulge cells, which in turn provide signals that 
attract the muscle to this site [38]. At the upper bulge and isthmus, epidermal cells closely 
interact with neural crest-derived precursor cells (NCPCs) that are associated with the 
endings of sensory nerve fibres, wrapping around each HF [39,40]. The nerve fibres have 
been shown to also influence epidermal stem cells by secretion of Sonic hedgehog (Shh) 
ligand, which activates Hedgehog (Hh) signalling in the upper bulge [34]. Melanocyte stem 
cells are another neural crest-derived cell type within the bulge niche. The survival and 
activation of melanocytes closely relies on signals provided by epidermal stem cells [41,42]. 
Evidence is accumulating that immune cells can modulate HF stem cells, for example by 
secretion of growth factors during wound healing [43]. Lastly, the composition and rigidity of 
the extracellular matrix have profound effects on the properties of epidermal stem cells. The 
basement membrane is mainly composed of laminins and type IV collagen and the basal cells 
attach to it via integrin receptors. This interaction is crucial for maintaining stem cell potential 
and tissue homeostasis as cells that lose this connection start to differentiate [9]. Furthermore, 
it was discovered that the mechanical properties of the surroundings, such as matrix stiffness 
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and density, can alter the stem cell fate [44]. Constraining the physical shape of keratinocytes 
to small cell sizes induced differentiation while stretched out cells kept dividing, which 
implies that epidermal differentiation can be directed by mechanical signals [45]. 
 
1.1.4 The sebaceous gland 
SGs are holocrine glands, producing sebum from fatty acids that lubricates the hair shaft and 
supports the barrier function of the IFE. One or two SGs are typically connected to the upper 
part of dorsal HFs and are regarded as a HF compartment in this thesis. Basal cells in the SG 
are frequently proliferating, giving rise to differentiating sebocytes within the gland. Mature 
sebocytes travel towards the SG duct, where they burst and release their oily contents into the 
hair canal [46]. 
During embryonic development, the SG is generated from Lrig1+ cells in the upper part of the 
HF shortly after the induction of the hair germ [47]. The signalling pathways that positively 
regulate SG differentiation include c-Myc [48] and Hh signals [49]. Conversely, activation of 
the Wnt/β-catenin pathway blocks SG development [50], and inhibition of the Wnt-
associated transcription factor LEF1 results in de novo SG formation [51], implicating 
canonical Wnt signalling as a key regulator of the fate choice between SG and HF lineage. 
Moreover, sebocyte differentiation is significantly affected by sex hormones; especially 
androgens stimulate SG growth [52]. 
The mode of SG renewal and the identity of SG stem cells are still a matter of debate. Blimp1 
was first presented as a marker specific to SG progenitor cells, locating SG progenitors at the 
opening of the gland [53]. However, inducible lineage tracing from the Blimp1 promoter 
revealed that Blimp1 is in fact expressed in differentiated cells within the SG and the IFE, and 
thus Blimp1+ cells unlikely represent SG precursor cells in adult mice [54]. Nevertheless, 
several other studies presented evidence for the existence of a local, self-maintaining SG 
progenitor cell population. HF-independent maintenance of the SG was observed by 
randomly labelling epidermal cells for lineage analysis [55]. Furthermore, Lrig1 and Lgr6, 
which are both expressed in the SG basal layer, were suggested as putative markers of SG 
progenitor cells [35,54]. In contrast, contributions of bulge (Krt15+), isthmus (MTS24+ and 
Lgr6+) and junctional zone (Lrig1+) cells to SG maintenance were proposed by lineage 
tracing experiments using different HF stem cell markers [32,33,36,56]. Thus, it remains to 
be resolved if and how different HF stem cells contribute to the SG during homeostasis. 
 
1.1.5 Stem cell dynamics in the interfollicular epidermis 
Since the HF bulge is the only epidermal compartment containing slow-cycling, quiescent 
stem cells, it was questioned whether the IFE contains an autonomous stem cell population or 
if it is also maintained by HF stem cells. Several early reports concluded that HF cells 
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generally take part in the homeostatic turnover of the IFE [24,57]. However, more recent 
studies, using genetic labelling techniques, presented compelling evidence for the existence 
of independent IFE stem cells. By permanently labelling all HF cells, using either the Shh or 
Sox9 promoter during development, two studies demonstrated that the IFE is not traced 
during normal tissue maintenance, indicating that HFs and IFE contain separate stem cell 
pools [58,59]. 
Until today, no specific stem cell markers for the IFE have been identified. The basal markers 
K5, K14 and p63 are found in all epidermal basal cells and generally mark the 
undifferentiated status throughout the epidermis [60]. In human IFE, a few markers have 
been suggested, such as high levels of β1 integrin [61]. So the question remained how 
epidermal stem cells are defined. The first theories originated from the observations of 
keratinocytes in culture and murine epidermis after irradiation. Seeding keratinocytes at low 
density, distinct types of clonal colonies are detected, indicating a proliferative heterogeneity 
amongst basal epidermal cells. From the number of clonogenic cells and the diverse 
differentiation capacities, a hierarchical model was proposed of slowly dividing stem cells 
that give rise to transit-amplifying (TA) cells with limited proliferation potential, which 
eventually give rise to differentiated, suprabasal cells [62,63] (Figure 6A). This hypothesis 
was supported by the architecture of stratified epidermis, forming regular stacks of 
keratinized cells with an underlying group of basal cells (Figure 2). In each of these 
epidermal proliferative units a central slow-cycling stem cell is surrounded by a number of 
TA cells, which generate the differentiated cells on top. 
 
Figure 6. Models of stem cell renewal in the interfollicular epidermis. 
(A) This model describes a cluster of a stem cell (red) with surrounding transit-amplifying (orange) and 
differentiated cells (yellow) as an epidermal proliferative unit, each one underlying a stack of 
hexagonally shaped keratinocytes in the strateum corneum. The different cell types arise in a strict 
hierarchy and have distinct characteristics. (B) The committed progenitor model describes the basal 
layer as composed of cells with progenitor potential (purple) and post-mitotic cells (green). Progenitor 
cells stochastically follow one of the three depicted fates to generate progenitor and post-mitotic 
cells, which then give rise to differentiated cells in the upper layers of the IFE. 
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In 2007, Clayton and colleagues conducted a pioneering study, uncovering that progenitor 
cells in the IFE basal layer chose their cell fate stochastically, instead of following a strict 
hierarchy [64]. Based on the clone size distributions of randomly labelled basal cells in tail 
epidermis, they reconstructed the underlying mode of stem cell renewal using mathematical 
probability models. The “committed progenitor” model states that all IFE progenitor cells 
have the same proliferation potential and follow one of three fate options after division: two 
progenitor cells, one progenitor cell and one post-mitotic basal cell, or two post-mitotic basal 
cells (Figure 6B). Post-mitotic cells will eventually differentiate and exit the basal layer. 
Hence, by symmetric divisions the progenitor cell pool is either enlarged (two progenitors) or 
diminished (two post-mitotic cells). To ensure tissue homeostasis, both processes must occur 
at the same rate. This mode of epithelial regeneration was later also confirmed in the 
epidermis of the ear [65] and paw [66], and in many other rapidly renewing tissues, such as 
the intestine [67], oesophagus [68], and stomach [69]. It should be noted that the committed 
progenitor model is a convincing model, which describes the experimental observations 
accurately. However there are no means (yet) to distinguish progenitor cells from the post-
mitotic basal cells experimentally. Hence, the factors that determine the progenitor cells 
remain to be discovered. 
 
1.1.6 Lgr5 and Lgr6 as stem cell markers 
Lgr5, a leucine-rich repeat containing G protein-coupled receptor, became known as the first 
marker gene for intestinal stem cells, the so-called crypt base columnar cells [70]. The group 
of Hans Clevers originally identified Lgr5 as a Wnt target gene specifically expressed in the 
intestinal crypt [71,72]. Since no functional antibodies were available against LGR5, they 
subsequently developed knock-in mouse strains to detect Lgr5-expressing cells and test their 
stem cell properties by lineage tracing experiments. The Lgr5+ stem cells that gave rise to all 
lineages of the intestine in long-term lineage tracing were rapidly proliferating and did not 
sustain DNA-label incorporation [70]. Thus, the discovery of Lgr5+ stem cells challenged the 
paradigm of the slow-cycling, label-retaining tissue stem cell that gives rise to transit-
amplifying cells, which had been the prevailing view of how adult tissues are maintained by 
mostly quiescent stem cells [73]. 
Shortly after this breakthrough, Lgr5+ cells were discovered within the murine HF, using the 
same genetic tools [27]. Lgr5+ cells are located in the lower bulge and hair germ of the 
telogen HF (Figure 7A), and are not DNA label-retaining, in contrast to most CD34+ bulge 
cells. In the anagen HF, Lgr5 is expressed in the ORS of the lower HF bulb. Upon isolation 
and transplantation onto the back of immune-compromised nude mice, Lgr5+ cells 
demonstrated the potential to give rise to all lineages of the epidermis, including HFs, SGs, 
and IFE, indicating that Lgr5+ cells are multipotent stem cells [27]. At the molecular level, 
Lgr5+ cells are characterized by active Hh signalling and transcription of Wnt pathway 
components. During homeostasis, telogen Lgr5+ cells in the hair germ are the first cells to 
respond to the anagen-inducing signals by the dermal papilla and start proliferating to 
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generate the anagen HF. Lineage tracing revealed that Lgr5+ cells of the lower bulge and hair 
germ contribute to all layers of the anagen bulb and sometimes to the isthmus [27]. 
Interestingly, Lgr5+ cells in the lower ORS, labelled in anagen, survive the catagen phase and 
repopulate the hair germ in the subsequent telogen, showing that ORS cells also have a 
certain stem cell potential and are not entirely lost by apoptosis during catagen. These results 
emphasize the notion that long-term surviving stem cells are not necessarily slow-cycling and 
label-retaining [74]. The quiescent cells in the bulge may serve as a back-up population that 
replenish the actively cycling stem cell pool and participate in wound repair, rather than 
contributing to routine tissue turnover [73]. Lgr5 has since been defined as stem cell marker 
in various other organs such as stomach [75], mammary gland [76], taste buds [77] and 
kidney [78], underlining the importance of Lgr5 as a general marker of adult epithelial stem 
cells. 
 
 
Figure 7. Expression of Lgr5 and Lgr6 in the telogen hair follicle. 
(A) Lgr5 is exclusively expressed in cells of the hair germ and lower bulge. (B) Lgr6 expression is 
strongest in the isthmus region, but is also detectable in the basal layer of the sebaceous gland and 
interfollicular epidermis, as well as in some cells in the inner layer of the bulge. Insets show EGFP 
expression in Lgr5/6-EGFP-IRES-CreERT2 dorsal skin tissue. 
 
Shortly after Lgr5 was established as a HF stem cell marker, the expression of the 
homologous genes Lgr4 and Lgr6 was analysed in the skin using LacZ reporter mice [33]. 
The highest levels of Lgr6 were found in the central HF isthmus, while Lgr4 expression was 
detected in the entire HF below the infundibulum. During HF morphogenesis, Lgr6 starts to 
be expressed already in the earliest hair placodes at E14.5. Like Lgr5+ HF cells, Lgr6+ cells 
are rapidly dividing and do not retain DNA labelling. Lineage tracing in adult mice, using an 
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Lgr6 knock-in mouse line, revealed that Lgr6+ cells mainly replenish cell pools in the 
isthmus, SG, and IFE during homeostasis, demonstrating a long-term stem cell capacity. 
When isolated and transplanted, Lgr6+ keratinocytes were able to reconstitute entire HFs and 
epidermis, implying an intrinsic multipotent stem cell potential [33]. 
In contrast to Lgr5, Lgr6 gene expression does not seem to be regulated by Wnt signals [33]. 
Recently, it was implicated that Lgr6 expression in the epidermis is more widespread than 
previously recognized, being additionally detected in the basal layer of the IFE and the SG 
(Figure 7B) [35,79]. Moreover, a connection between Lgr6 reporter activity and sensory 
nerve fibres in the skin was observed [79], providing a new indication of the regulation and 
function of Lgr6. 
Molecularly, LGR4, LGR5 and LGR6, belong to the class of 7-transmembrane, G protein-
coupled receptors. On the extracellular domain they contain 13-17 characteristic leucine-rich 
repeat elements (17 in LGR4 and LGR5, 13 in LGR6), forming a ternary horseshoe shape 
[80]. When the Lgr5 gene is deleted in mice, the pups die shortly after birth due to 
malformation of the palate, indicating an involvement of Lgr5 in murine development [81]. 
Lgr6-null mice, however, are viable and fertile [33]. 
 
 
Figure 8. The canonical Wnt signalling pathway and the putative role of Lgr5. 
In absence of Wnt ligands, β-catenin is tagged for degradation in the cytoplasm by a destruction 
complex, composed of Axin, adenomatosis polyposis coli (APC), and glycogen synthase kinase 3 
(GSK3) (left panel). When Wnt binds to the Frizzled receptor, they form a complex with the co-
receptors Lrp5/6 at the cell surface (right panel). This leads to the recruitment of Axin via the 
scaffolding protein Dishevelled (Dvl), resulting in inactivation of the destruction complex and 
accumulation of β-catenin, which translocates to the nucleus, where it binds to TCF transcription 
factors to activate Wnt target genes. The proposed role of Lgr5 is to enhance Wnt signalling by 
binding R-spondin molecules, which inactivates the E3 ubiquitin ligases ZNF3 and RNF43 that 
normally down-regulate Frizzled. 
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Recently, it was uncovered that R-spondins are the ligands for LGR4 and LGR5 [82-86]. R-
spondins were already known to be secreted activators of Wnt/β-catenin signalling, acting as 
mitogens during development [87]. Being a Wnt-responsive gene, the LGR5 receptor now 
classifies as a part of the Wnt signalling complex at the cell surface (Figure 8). However, the 
exact molecular mechanism how the LGR5/R-spondin interaction leads to enhanced Wnt 
signalling is not clear. It is speculated that the LGR5/R-spondin complex increases the Wnt 
receptor levels on the cell surface by sequestering the E3 ligases RNF43/ZNF3 that tag the 
receptors for degradation [88]. 
 
 
1.2 WOUND HEALING 
 
Wound healing is a vital mechanism to rebuild tissue following an injury, which often results 
in the formation of a scar. The sequence of this complex process is very similar in various 
tissues and involves the orchestration of many different cell types [89]. The cutaneous wound 
healing process can be divided into four distinct phases: (1) immediate response, (2) 
inflammation, (3) new tissue formation, and (4) remodelling [89,90]. The first stage of wound 
healing in the skin is the formation of a platelet clot that coagulates the blood vessels to stop 
the bleeding. The blood clot also serves as a temporary scaffold for recruited cells and 
releases various growth factors and other signalling molecules [90]. In the second phase, 
circulating and skin-resident immune cells appear at the wound site. First are the neutrophils 
and later monocytes arrive, which differentiate into macrophages to defend the body against 
pathogens and clear cell debris [91]. In the third phase, the cells regenerating the new tissue 
invade the wound. Keratinocytes migrate and proliferate as they move from the wound edge 
to the centre of the wound to establish the new epidermis, a process called re-epithelialisation 
[89]. Within the dermis, fibroblasts synthesise collagen, the main substrate of the scar tissue, 
and differentiate into contractile myofibroblasts, which promotes wound closure by 
contraction [92,93]. Moreover, angiogenesis and lymphangiogenesis are initiated. The last 
phase describes the restoration of the skin structure and function by remodelling and 
refinement of the structures over longer periods of time. All of these processes need to be 
tightly regulated to ensure the arrest of proliferation and prevent overproduction of tissue, 
resulting in fibrosis or excessive scarring [89]. 
As impressive as the regeneration of skin is, the newly formed scar tissue does not 
completely regain all of its functionality and components as before wounding. First and 
foremost, all appendages are lacking, which usually contribute to the skin’s physiology [94]. 
In addition, scar tissue shows altered biomechanical properties, such as reduced elasticity 
[95]. Interestingly, it was recognised that human foetal skin has the ability to heal without 
scarring [96,97]. The main difference between foetal and adult skin is the lower number of 
immune cells in foetal skin, which led to the establishment of the theory that the 
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inflammatory reaction constrains the regenerative potential of adult skin and promotes 
scarring [94,98]. 
The role of epidermal stem cells in the wound healing process has been intensely 
investigated. The keratinocytes required for wound re-epithelialisation derive from the 
surrounding IFE and the appendages. A study using mice which display a lack of tail HFs 
(ectodysplasin-A receptor-associated death domain knockout mice), proved that HFs are not 
essential for wound healing but they accelerate wound closure [99]. Intriguingly, the rate of 
wound healing is correlated with the number of HFs in anagen and is consequently fastest in 
areas such as the scalp, where the density of anagen HFs is the highest [100]. Lineage tracing 
of HF cells revealed that HF stem cells participate substantially in the re-epithelialisation of 
cutaneous wounds [101]. Even dormant stem cells located in the HF bulge, marked by K15 
expression, are activated and recruited to aid in wound closure [102]. Also stem cells located 
in the lower isthmus, junctional zone and infundibulum were shown to contribute to 
epidermal regeneration [34,35,99]. These studies demonstrate the plasticity of epidermal stem 
cells, which are able to convert their fate from an appendage stem cell to an IFE stem cell in 
the newly generated epithelium covering the scar [103]. 
It will be interesting to explore the molecular mechanism governing this conversion of cell 
fates. Several experiments started elucidating the lineage conversion between IFE and HF 
cells. It was shown that canonical Wnt signalling is able to induce the formation of ectopic 
HFs from existing HFs or IFE when constitutively activated, e.g. in the form of β-catenin 
with a nuclear translocation domain [50,104,105]. Conversely, repression of Wnt signalling 
by expression of a dominant negative ∆N-LEF1 leads to a switch from HF differentiation to 
stratified squamous epithelium [51]. 
In a striking experiment Ito and co-workers showed that de novo formation of fully 
functioning HFs is possible in wild type mice, by introducing sufficiently large full-thickness 
wounds on dorsal skin [106]. The growth of the HFs in the middle of the scar epidermis 
closely resembled the naturally occurring HF morphogenesis, with Wnt/β-catenin as the 
initial inductive signal. Further studies revealed that an increased number of fibroblasts in the 
upper dermis, which is permissive for HF formation, and the secretion of fibroblast growth 
factor 9 from γδ T cells within the dermis are important factors in this process [43,107]. The 
cellular source for de novo HFs were the IFE and the infundibulum, and not bulge stem cells 
[106]. This again is very similar to the developmental HF morphogenesis and highlights the 
flexibility of keratinocyte lineages. 
The activation of stem cells to repair damaged tissue is crucial, however, the cell proliferation 
and recruitment during wound healing must be tightly controlled to prevent cancer 
development. It has long been observed that tumour formation is promoted at sites of chronic 
wounds and fibrotic tissues, and there are many intriguing similarities between wounds and 
tumours [108]. Both, healing wounds and tumours exhibit leaky vessels, deposition of 
fibrin/fibronectin, and ongoing angiogenesis [109]. There is an established connection 
between tumour development and the inflammatory response, which is characterised by the 
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infiltration of symptomatic immune cells, such as M2 macrophages, and the production of 
reactive-oxygen species [109-111]. Further similarities between wounds and skin tumours are 
the migration and proliferation of keratinocytes, which are often stimulated by the same set of 
mitogens, the differentiation of fibroblasts into myofibroblasts, and the conversion of 
epithelial cells to mesenchymal-like cells [108,109,112]. During normal wound healing those 
processes are naturally controlled and terminated to re-establish tissue homeostasis. But when 
cells are transformed by oncogenic mutations, the wound environment can start to advance 
tumour growth. 
 
 
1.3 SKIN CANCER 
 
As the outermost layer of the body, the epidermis is constantly exposed to UV radiation and 
potentially harmful chemical substances. Thus, skin cancer is the most commonly diagnosed 
form of cancer [113]. The different types of keratinocyte-derived tumours are referred to as 
non-melanoma skin cancer (NMSC) and comprise the two most common forms, basal cell 
carcinoma (BCC) and squamous cell carcinoma (SCC), and other rare cancers, such as 
trichofolliculoma and sebaceous adenoma. 
The epidermis and other epithelial tissues, such as the intestinal epithelium, proliferate 
intensely during homeostasis. On the one hand this ensures a constant replacement of 
damaged and dead cells. But on the other hand high cellular turnover rates increase the 
chances that a cell carrying a DNA mutation propagates. The transformation of a normal cell 
into a cancer cell usually requires multiple genetic mutations and each round of cell division 
raises the probability of such events to manifest [114]. The most common genetic lesion 
detected in NMSC is the mutation of the p53 tumour-suppressor gene. More than 90% of 
SCCs and 50% of BCCs show UV-induced p53 mutations [115]. The same p53 mutations are 
even found in normal skin and the precancerous stages of skin neoplasms, like actinic 
keratosis [116,117]. 
Modelling the process of skin carcinogenesis in mice facilitates the comprehension of the 
early steps of tumour development. Tumour induction is classically achieved by treatment 
with carcinogenic chemicals, mimicking the natural evolution of a tumour with successive 
mutational events. This model is referred to as multistage carcinogenesis and involves the 
topical application of a carcinogenic compound e.g. 7,12-dimethylbenz[a]anthracene 
(DMBA) followed by the repetitive treatment with a tumour promoting substance such as the 
phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) [118]. This procedure typically 
induces mutations of H-Ras as the driver oncogene, leading to the emergence of benign 
papillomas, which then progress to SCC [118,119]. Furthermore, UV irradiation and genetic 
mouse models with specific activation of certain oncogenes or knockout of tumour-
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suppressor genes are used to study the initiation and progression of skin tumours. Even 
though there are certain differences between humans and mouse models that need to be taken 
into consideration, the general mechanism of NMSC development is comparable in both 
species [120]. 
 
1.3.1 Cancer cells-of-origin – the role of stem cells in tumourigenesis 
The variety of NMSC types, or generally the fact that different types of cancer arise within 
the same tissue, raises several questions: Do different tumour types arise from different cell 
types? Can one cell type give rise to multiple tumour phenotypes, depending on the acquired 
mutations? Or can the same type of tumour even arise from different cell types? Especially 
for therapeutical intervention it is important to elucidate whether some cells are more prone to 
generate cancer than others and which cell types are the main targets for tumourigenic 
transformation. 
Defining the “cancer cell-of-origin” and answering the above questions is therefore a major 
goal in basic cancer research. The term cancer cell-of-origin describes the cell which has 
experienced the first mutagenic event that led to tumour development, and should not be 
confused with “cancer stem cell”, which often denotes certain cells belonging to an already 
established tumour that sustain tumour growth [121]. 
As many tumour tissues resemble one particular cell type, in regards to histology and marker 
expression, it seems intuitive that this cell type is also the source of tumour cells. Hence, the 
cellular origin of the tumour was, and still is, indirectly inferred based on these correlations. 
However, several examples have shown that this is not always the case, and only experiments 
in vivo, for example targeted transformation and lineage tracing, can prove that a given cell 
type or stem cell population can give rise to a certain cancer [121]. It is possible that the 
altered signalling cascades in a transformed cancer cell lead to transdifferentiation into 
another cell type or change the lineage fate of a cancerous stem cell. Likewise, cells further 
down the differentiation pathway may dedifferentiate to a stem cell-like state upon malignant 
transformation, which has been experimentally demonstrated in the mammary gland and the 
intestine [122,123]. 
There are several examples where the apparent cell type of the tumour cells did not match 
that of the experimentally determined cell-of-origin. Breast cancer arising in BRCA1 mutant 
individuals with a stem cell-like (basal-like) appearance were shown to have developed from 
expanding luminal cell populations and not from the basal mammary gland stem cells [124]. 
Similarly, BCC cells generally resemble undifferentiated HF cells and were therefore 
believed to arise from ORS cells [114]. However, lineage-tracing experiments in mice have 
demonstrated that BCCs do not only arise from stem cells of the HF but can also evolve from 
IFE basal cells [28,125,126]. 
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Tissue stem cells have been in the focus of the search for the cancer cell-of-origin because 
stem cells already possess unlimited life-span, active growth signalling pathways, and a 
multipotent status [114]. Experiments using multistage carcinogenesis have shown that 
mutations induced by DMBA treatment can persist for a long time before the final promotion 
phase triggers cancer development, implying that long-lived stem cells are targeted by the 
mutagenesis [127]. Directly introducing activated H-Ras into epidermal keratinocytes showed 
that more aggressive tumours (such as SCC) occur when basal cells are targeted instead of 
suprabasal cells, which only generate benign pre-cancerous papillomas [128,129]. Moreover, 
the signalling pathways that are deregulated in NMSCs are associated with stem cell 
regulation in normal tissue, such as Hh, Wnt/β-catenin and Bmp signalling [113]. 
 
1.3.2 Hedgehog signalling 
The Hh pathway has been recognised as the main driver of BCC and medullablastoma, which 
is exceptional because a single event, i.e. the mutation of one pathway component is 
sufficient to initiate tumour formation [130]. In normal physiology, the three mammalian Hh 
molecules Sonic hedgehog, Desert hedgehog and Indian hedgehog act primarily as 
morphogens during embryonic development [131]. By forming long- or short-ranged 
concentration gradients, the Hh ligands are involved in the specification of a plethora of 
different cell types and the development of different organs, including limbs, bones, muscles, 
and neurons [131]. In the adult organism, Hh signalling plays a role in stem cell maintenance 
in the brain, skin, teeth, and several other organs [132]. 
The Hh signalling pathway exhibits a unique signalling cascade to transduce signals from the 
cell surface to the nucleus (Figure 9). The secreted ligands are bound by the 12-
transmembrane receptor Patched 1 (PTCH1) and its homologue PTCH2. The receptor forms 
a complex with several co-receptors to increase Hh ligand binding affinity [133]. When no 
ligands are present, Ptch receptors are present at the cell surface, in a specialised protuberance 
called primary cilium, and prevent the appearance of the G protein-coupled receptor 
Smoothened (Smo) at the cell surface. Signalling along the primary cilium, involving casein 
kinase 1α (CK1), protein kinase A (PKA), and glycogen synthase kinase 3β (GSK3β), leads 
to proteolytic processing of the Gli transcription factors into their repressor form [132]. There 
are three Hh-mediating transcription factors in mammals, GLI1, GLI2 and GLI3. The C-
terminus of both GLI2 and GLI3 can be proteolytically cleaved off. In this truncated form 
they act as a transcriptional repressor, while the full-length conformation activates 
transcription of Hh target genes in the nucleus. In contrast, GLI1 only exists in its full-length 
form as a transcriptional activator. Interestingly, Gli1 and Gli2 are themselves target genes 
activated by Hh signalling, generating a positive feedback loop [134]. Upon binding of the 
Hh ligands to Ptch, it moves out of the primary cilium, releasing the blockage of Smo, which 
is consequently recruited to the cilium. This leads to the accumulation of the full-length 
activator forms of the Gli transcription factors, which then translocate to the nucleus to 
induce expression of Hh target genes [132]. Among the primary Hh-induced genes is Ptch1, 
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resulting in a negative feedback response. However, the molecular mechanisms underlying 
the suppression of Smo activity by Ptch and how the downstream signalling from Smo to Gli 
is mediated are still largely unsolved [133]. 
 
 
Figure 9. The Hedgehog signalling pathway (simplified). 
In absence of ligand, Patched (Ptch) receptors are present at the cell surface and inhibit signalling of 
Smoothened (Smo). This causes cleavage of Gli transcription factors into a repressor form (Gli-R). 
Upon binding of the Hedgehog ligand (Hh) to Ptch, the inhibition of Smo is released. Through a 
largely unknown mechanism, Smo now permits the accumulation of the Gli activator form, which 
acts as a transcriptional inducer. Important target genes of the Hh pathway are Gli1 and Ptch1, 
creating regulatory feedback loops. 
 
In the skin, Shh signalling was demonstrated to have a vital role in the early HF 
morphogenesis as development beyond the placode stage is abrogated in Shh knockout mice 
[135,136]. During the normal cycling of mature HFs, Shh is responsible for anagen induction, 
along with Wnt/β-catenin and Noggin (Bmp inhibition) [16,137]. Shh is also expressed in the 
matrix of the anagen HF, where it promotes proliferation of epithelial cells [138]. In line with 
the importance of the Hh pathway in HF specification and proliferation, ectopic activation of 
Hh signalling in epidermal cells leads to BCC initiation. The tumourigenic process closely 
mimics the early phases of HF development, which is reflected in a similar palisading cell 
morphology and overlapping gene expression profiles [139,140]. 
Less is known about the function of active Hh signalling in the resting telogen HF. The 
telogen dermal papilla and hair germ were shown to express Gli1, Gli2, and Gli3, with Gli2 
expression additionally being present in the basal layer of the bulge [34]. As a reliable 
readout for Hh activity, Gli1 expression was also detected at the bulge-isthmus border of the 
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HF, where the sensory nerve fibres come into contact with the epithelial HF cells [34]. 
Potential sources of the Hh ligands are the nerve fibres close to the isthmus [34], and the 
dermal papilla, providing Hh ligands to the hair germ [141]. Low levels of Shh mRNA were 
also detected in the Lgr5+ hair germ and bulge cells [27]. 
 
1.3.3 Basal cell carcinoma 
BCC belongs to the group of NMSC and is the most common form of cancer diagnosed in 
individuals of European descent [142]. In contrast to SCC, which is often invasive and can 
cause mortality, BCCs are typically benign tumours and very rarely metastasise [142-144]. 
However, the fact that the aetiology of BCC is very well defined, compared to other types of 
cancer, renders it an ideal tumour type to study cancer initiation and development in pre-
clinical models [145]. 
UV light is a major mutagenic driver of BCC carcinogenesis, as there is a high correlation 
between cumulative sun exposure and BCC incidence, and BCC more often develops in sun-
exposed body areas, such as the face and limbs [146]. BCCs frequently appear as pale lesions 
that may be ulcerated or pigmented and grow into the dermis as nodules or strings [147]. The 
primary cell mass of the tumours consists of keratinocytes that resemble undifferentiated 
basal cells, and express K5, K14, K17, Sox9 and CDP, which are also markers of the early 
HF buds during embryonic development [139]. 
The development of BCC is closely linked to the specific deregulation of the Hh signalling 
pathway. Genetic linkage analyses of sporadic BCCs and patients with basal-cell nevus 
syndrome (or Gorlin syndrome) revealed mutation or loss of the PTCH1 gene locus as the 
primary cause of BCC [148-150]. Up to 90% of sporadic BCCs carry mutations of the 
PTCH1 receptor [151]. The role of the Ptch receptor is to release suppression of Hh 
signalling upon ligand binding. Thus, inactivating mutations or loss of PTCH1 activates the 
pathway even in absence of ligands. On the other hand, 10% of BCC patients show activating 
mutations of Smo, which acts downstream of Ptch [142]. Patients with Gorlin syndrome 
predominantly carry a heterozygous germ line mutation of PTCH1, rendering them highly 
susceptible to development of BCC and other neoplasms [152]. 
The primary target for clinical therapy of advanced BCC is inhibition of Smo activity. The 
most common drug in clinical use, Vismodegib, acts in a similar manner as the naturally 
occurring Hh inhibitor cyclopamine [153]. Yet, around 20% of cases develop Smo mutations, 
causing resistance to Vismodegib and recurrence of the disease [154,155]. 
A remarkable fact about BCC is that in contrast to other cancer types, it is not possible to 
maintain BCC cells in culture conditions for extended periods nor to transplant these cells as 
xenografts [142]. Therefore, animal models of BCC are a major resource for gaining insights 
into the molecular mechanisms of BCC development, interactions with the tumour stroma, 
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and drug responses. Importantly, cutaneous BCC development can be easily triggered by 
introduction of mutant components of the Hh pathway [145,156]. 
 
 
1.4 GENETIC TOOLS 
 
Genetic mouse models are ideal to decipher the expression and function of a specific gene, 
and study the effects of activating a certain pathway in vivo. In the studies of this thesis 
several different systems were combined to detect, label and manipulate epidermal stem cells 
in mice. 
To detect the expression of Lgr5 and Lgr6, and initiate lineage tracing or other genetic 
manipulations in Lgr5+ or Lgr6+ cells, Lgr5/6-EGFP-IRES-CreERT2 knock-in mice were 
used. In these mice that will be referred to as Lgr5Cre and Lgr6Cre mice, the enhanced green 
fluorescent protein (EGFP) gene sequence was inserted behind the endogenous promoter, 
replacing the Lgr5/6 transcript. Thus, all cells that naturally express Lgr5/6 can be identified 
by EGFP fluorescence, which is of particular advantage because no antibodies specific to 
LGR5 or LGR6 were available. 
The second part of the inserted gene sequence contains an internal ribosomal entry site 
(IRES) and a fusion protein of the Cre recombinase with a modified oestrogen receptor 
(CreERT2). The IRES sequence allows a second protein (CreERT2) to be generated from the 
same mRNA, containing both the EGFP and CreERT2 coding sequences. The Cre 
recombinase is a bacteriophage P1 enzyme which is able to cut and re-ligate DNA sequences 
that are flanked by a specific Cre recognition sequence, called LoxP site [157]. With the 
addition of the oestrogen receptor-binding domain, the activity of the Cre enzyme can be 
controlled by exploiting the nuclear shuttling mechanism of the oestrogen-bound receptor 
[158]. When the oestrogen analogue tamoxifen is administered to the cells expressing 
CreERT2, the Cre relocates to the nucleus where it can exert DNA recombination 
(Figure 10A). This mechanism provides a tight temporal control of the genetic manipulation. 
By placing the expression of Cre under a specific promoter, the Cre/LoxP system can be used 
for inducible lineage tracing of cells expressing the gene-of-interest. To this end, an 
additional allele carrying a conditional reporter gene has to be present in the mouse genome. 
These reporter alleles contain a LoxP-flanked stop sequence in front of the protein coding 
sequence that is removed upon Cre recombination, allowing subsequent stable expression of 
the reporter (Figure 10B). The reporter sequences are typically inserted into the genomic 
locus of a gene called Rosa26 (R26), which is ubiquitously expressed [159]. Genes 
commonly used as reporter include fluorescent proteins (EGFP and derivatives) or LacZ, 
coding for β-galactosidase. Hence, after successful Cre recombination, the targeted cell (or 
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cell population) is permanently labelled by the reporter expression. Since the genetic 
modification is not reversible, all progeny of this cell is also labelled, which makes it possible 
to distinguish the cells that are derived from the originally targeted cell. In lineage tracing 
experiments, the entity of labelled cells that are derived from one cell are referred to as a 
“clone”. 
 
 
Figure 10. Mechanism of Cre/LoxP recombination and genetic lineage tracing. 
(A) 1. The first exon (E1) of a gene is flanked by LoxP sequences (yellow triangles). The LoxP sites 
serve as recognition sites for the Cre recombinase. 2. The DNA sequence located between two 
forward-facing LoxP sites is removed by a Cre-mediated enzymatic reaction. 3. After re-ligation of 
the DNA, one LoxP sequence is retained. (B) A cell of an Lgr6Cre/Tomato mouse with active Lgr6 
promoter expresses EGFP and CreERT2 recombinase. Tamoxifen binds to the ERT2 domain of the 
Cre fusion protein, leading to nuclear translocation of the Cre complex. Within the nucleus, Cre 
mediates the recombination of genomic DNA flanked by two LoxP sites. Thereby the stop codon in 
front of the reporter allele is removed. Subsequently, the Tomato fluorescent dye is permanently 
expressed in this cell and all of its progeny. 
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Figure 11. The Confetti multicolour reporter construct. 
The Confetti cassette, inserted in the Rosa26 locus, contains a stop codon (pGK neo) and the genes 
encoding nuclear GFP (nGFP), cytosolic YFP and RFP, and membranous CFP (mCFP). The LoxP 
sites (yellow triangles) are arranged around the elements so that they permit either excision of the 
sequence between two LoxP sites oriented in the same direction or inversion of the sequence 
between two opposing LoxP sites. Thus, Cre recombination generates a random outcome of reporter 
expression. The inset depicts Lgr6Cre/Confetti traced epidermis with clones in all four colours, 
scanned by confocal microscopy. pA: polyadenylation signal. 
 
To track the fate of individual stem cells or tumour-initiating cells, a high clone frequency 
and merging of clones need to be avoided. For this purpose multicolour reporters, in which 
the clone colour is randomly chosen for each labelled cell, offer considerable advantages over 
monochromatic reporters. Making use of the wide range of engineered fluorescent proteins, 
the first fluorescent multicolour reporter constructs, called Brainbow, were developed by Jeff 
Lichtman’s group in Harvard and successfully used in mice to individually label neurons 
during development [160]. The Confetti construct used in the studies at hand is a modified 
version of the Brainbow-2.1, which has been inserted into the R26 locus and includes a stop 
codon that renders the reporter expression inducible [67]. Recombination of this construct 
leads to random excision and flipping of the LoxP-flanked parts, which is governed by the 
specific arrangement of LoxP sites around the genes encoding the four fluorescent proteins 
(Figure 11). The final state of the recombined allele will stably express one of the four 
fluorescent markers, thereby permanently distinguishing the offspring of the individual, 
targeted cell. 
Besides lineage tracing, the Cre/LoxP system was used to activate the Hh signalling pathway 
by conditional knockout of Ptch1. Exon 2 of the Ptch1 gene was encompassed by LoxP sites, 
to create a knockout upon Cre recombination [161]. This strategy closely mimics the 
aetiology of sporadic BCC in humans, as up to 90% of patients show inactivating mutations 
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of PTCH1 [151]. Another mechanism that was used to induce BCC development in a mouse 
model is the tet-off system. This strategy is based on the bacterial tetracycline (tet) operon, 
and allows control of gene expression by administration of tetracycline or derivatives, such as 
doxycycline [162]. To specifically express a gene-of-interest, the promoter must be replaced 
by a tet-response element (TRE) and the cells have to express the tet-transcriptional activator 
(tTA). In absence of tet, tTA binds to the TRE sequence and initiates transcription of the 
target gene but when tet is present and bound to the tTA, target-gene transcription is blocked. 
In our studies we employed the tet-off system to express the human GLI1 protein in basal 
cells. To this end, we used mouse lines with transgenic insertion of tTA under the control of 
the Krt5 promoter and the GLI1 gene sequence under the control of a TRE, and induced gene 
expression by doxycycline withdrawal. 
The biggest advantage of using mouse models to address biological research questions is that 
the cells are kept within their natural environment with all influencing factors present. In 
contrast, isolated cells or cell lines which have been sustained in culture over longer periods 
of time are subjected to highly artificial ex vivo conditions that change the nature of the cells, 
limiting the relevance of the conclusions. Hence, uncovering the natural behaviour of stem 
cells in homeostasis is only possible within a living organism. Moreover, organ development 
and contributions of distinct stem cell populations are difficult to recapitulate in cell culture. 
However, there are also certain drawbacks in the current in vivo models used in stem cell 
research. The inducing agents (e.g. tamoxifen and doxycycline) may cause side effects that 
perturb homeostasis and influence the outcome of the experiment [163,164]. Also the 
expression of the fluorescent proteins may be toxic or place the labelled cell population at a 
disadvantage [165]. Another challenge is real-time imaging, which is much harder to achieve 
in living animals compared to cell cultures. Thus, in our studies we had to rely on static “snap 
shots” of the traced clones to infer the dynamics of the stem cell expansion. A more general 
problem is the activation of a pathway beyond the physiological levels (e.g. by 
overexpression of a transcription factor), which limits the conclusions and the possible 
translation of the results to the human body. Moreover, ethical considerations come into play 
when using animals for research. It is critical to keep the number of mice to a minimum and 
ensure that the mice experience the lowest amount of inconvenience and suffering during the 
experiments. 
 
 
  23 
2 AIMS OF THE THESIS 
 
The general aim of this study was to investigate the role of Lgr5- and Lgr6-expressing 
keratinocytes during epidermal homeostasis, wound healing and tumour formation, and 
consequently compare the properties of stem cells in different compartments of the skin. 
 
Specific aims: 
 
Paper I Investigate the effect of wounding on BCC formation and the role of Lgr5+ HF 
stem cells in this process 
Paper II Identify the stem cell characteristics and molecular identity of Lgr6+ stem cells 
in different epidermal compartments (isthmus, SG, and IFE) during homeostasis 
Paper III Study the potential of Lgr6+ stem cells in different compartments to give rise to 
BCC and analyse the niche factors that influence their susceptibility 
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3 RESULTS AND CONCLUSIONS 
 
3.1 PAPER I 
Wounding enhances epidermal tumourigenesis by recruiting hair follicle 
keratinocytes 
BCC is one of the most common forms of cancer in humans and its incidence has been 
repeatedly associated with cutaneous wounds [109,166]. Although a prolonged inflammatory 
response has been shown to be one of the contributing factors [167], the cellular and 
molecular mechanisms how exactly wound healing affects skin cancer development were 
unknown. In this study we investigated the mechanism how wounding influences the 
tumourigenic capacity of epidermal and HF stem cells. 
To induce BCC in mice, we used several different mouse models, which activate Hh 
signalling in the skin. The first model enables ectopic expression of human GLI1 in all basal 
keratinocytes, by placing the GLI1 gene under the control of a tetracycline-responsive 
element (TREGLI1) and combining it with a K5-dependent tetracycline activator (K5tTA). In 
the second model, the Ptch1 gene is deleted in basal cells, by inducing a Cre-mediated 
knockout of Ptch1 in K5-expressing cells (K5Cre/Ptchfl/fl). Following activation of GLI1 
expression or Ptch1 knockout, both models showed extensive development of BCC-like 
lesions, arising in the HFs and IFE. 
When full-thickness wounds were introduced in K5tTA/TREGLI1 and K5Cre/Ptchfl/fl mice, 
we found that at the wound sites the BCC-like lesions were significantly larger and more 
progressed than in unwounded skin. In K5Cre/Ptchfl/fl mice additionally the number of lesions 
was increased at the sites of wounding compared to normal IFE. These results show that 
wounding has a profound impact on tumour growth, and in the Ptch1 deletion model also on 
the tumour initiation frequency. 
Since it is known that HF cells are mobilised to the wound during re-epithelialisation, we 
tested if the recruited HF cells are responsible for the enhancement of BCC development in 
wound areas. Using Lgr5Cre/LacZ/K5tTA/TREGLI1 mice to label and trace Lgr5+ cells 
during tumour initiation revealed that progeny of Lgr5+ HF cells indeed migrate to the IFE of 
scar epidermis and contribute to the formation of BCC-like lesions, while no contribution to 
IFE-associated lesions was detected in unwounded skin. 
To further support the notion that HF progeny can establish tumours in the wound epidermis, 
we generated Lgr5Cre/Ptchfl/fl mice to limit oncogenic transformation to cells of the lower 
bulge and hair germ. Activation of Hh signalling in Lgr5+ cells caused development of BCC-
like lesions that were restricted to the HF compartment. However after wounding, we 
detected multiple lesions in the wound epidermis, which shows that HF cells contribute to 
tumour formation in the IFE as a response to wound healing. Interestingly, only full-thickness 
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incision and excision of skin, or TPA treatment were sufficient to trigger emigration of Lgr5+ 
progeny to the IFE. Superficial wounding did not affect the tumour incidence. 
Taken together, our results indicate that the wound healing response causes HF cells carrying 
tumourigenic mutations to migrate and establish BCC growth in other epidermal 
compartments, thereby enhancing tumour development in wounded skin. 
 
 
3.2 PAPER II 
Dynamics of Lgr6+ progenitor cells in the hair follicle, sebaceous gland, and 
interfollicular epidermis 
Lgr6 was initially described to be a marker of multipotent stem cells in the HF, giving rise to 
cells in the isthmus, SG, and IFE [33]. However, the dynamics of stem cell renewal and the 
relationship between the lineages in the different HF compartments above the bulge were not 
known. The aim of this study was to fully characterize Lgr6 expression in adult dorsal skin 
and then study the fate of Lgr6+ cells in the different compartments, in order to elucidate the 
mechanism of epidermal regeneration by Lgr6+ stem cells. 
We employed heterozygous Lgr6Cre knock-in mice to visualise the expression of Lgr6 in the 
telogen HF and epidermis by EGFP fluorescence in tissue whole-mounts. The highest level of 
EGFP expression was detected in the lower and mid-isthmus of the HF, followed by medium 
EGFP expression levels in scattered cells in the basal layer of the IFE and SG, and in the 
inner bulge layer. When enhancing the signal EGFP by immuno-staining, we found rare cells 
expressing low levels of Lgr6 in the outer bulge and the dermal papilla. Cell sorting of 
Lgr6Cre keratinocytes revealed that around 20% of IFE basal cells are Lgr6-positive. 
However, there was no difference in the Lgr6-positive and -negative IFE population 
regarding the fraction of dividing cells, indicating that Lgr6 expression is not a general 
marker of proliferative epithelial cells, even though it is preferentially expressed in highly 
proliferative epidermal regions. 
To show that Lgr6+ IFE cells possess stem cell properties, we analysed lineage tracing using 
a multicolour fluorescent reporter strain (Confetti). Clones – labelled cells originating from a 
single labelled cell – developed from all compartments expressing high and medium level of 
EGFP (Lgr6): isthmus, SG, IFE, and inner bulge. Long-term analysis revealed that clones 
survived and expanded in all of these compartments except in the inner bulge, where cells do 
not divide. On the basis of the Confetti clone colours, we were able to determine that IFE 
clones evolve independently of HF clones. The colours of IFE clones did not match the clone 
colours in nearby HFs to a greater extent than expected for a random colour correlation of 
independent clones. These results confirm existing data that the IFE contains a separate stem 
cell pool [55,59,102] and establish that Lgr6+ cells function as IFE stem cells. 
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Since SGs also displayed Lgr6 expression as well as long-term surviving clones, we 
investigated the relationship between the Lgr6+ populations in the isthmus and the SG. It was 
not entirely clear if independent resident stem cells exist within the SG or if HF stem cells 
also replenish the SG, as no exclusive SG stem cell marker has been identified. We found that 
Lgr6+ derived SG clones were maintained over long-term tracing periods without any 
connection to the HF, indicating that Lgr6 also marks resident stem cells in the SG. 
Moreover, colour correlation analysis revealed that the percentage of SG clones with colour-
matched clone in the isthmus was not significantly greater than expected for a random 
correlation. Thus, the two compartments are presumably independent, although a minimal 
exchange of cells between the isthmus and the SG cannot be excluded. 
The next goal was to define the mode of stem cell renewal of the Lgr6+ populations in the 
three epidermal compartments. Recent work strongly supports that murine IFE is maintained 
by a single basal progenitor cell population that divides in a stochastic manner [64,65]. Thus, 
tissue regeneration is governed by the balanced stochastic fate outcome of the progenitor 
population as a whole (population asymmetry) as opposed to a selected stem cell population 
that strictly divides asymmetrically (stem cell asymmetry). Using lineage-tracing experiments 
the underlying population asymmetry can be detected by a stochastic clonal expansion, 
leading to increasing clone size and decreasing clone frequency over time. We tested these 
measures in the Lgr6+-derived isthmus, SG, and IFE Confetti clones. Remarkably, in all 
compartments the clonal behaviour accorded with the predicted outcome for population 
asymmetry. This suggests that even in other epidermal compartments with a more complex 
architecture than the IFE, population asymmetry is the underlying mode of tissue renewal, 
and the different populations likely have similar stem cell potency. 
Lastly, we investigated the differences between the individual Lgr6+ populations at the 
transcriptional level, to investigate whether the Lgr6+ populations are more similar to each 
other or rather represent the signature of their respective compartment. We isolated Lgr6+ 
cells from the IFE (SCA-1+) and the HF/SG (SCA-1–) by flow cytometry and performed 
RNA-sequencing. The gene expression profile of Lgr6+ IFE or HF/SG cells closely 
resembled the signature of the Lgr6-negative cells in the respective compartment and did not 
disclose a general gene set associated with Lgr6 expression. However, Lgr6+ HF/SG cells 
revealed several isthmus-specific genes such as defensin beta 6 (Defb6), cystatin E/M (Cst6) 
and parathyroid hormone-like peptide (Pthlh). 
In summary, this study closely examined the location, interaction and transcriptional 
networks of Lgr6-expressing stem cells in the skin. We found that Lgr6 expression in basal 
cells is not specific to any HF compartment, hair cycle phase or differentiation course, and is 
not strictly associated with the activity of a specific pathway. Moreover, the mode of stem 
cell renewal was identical in all independent Lgr6+ populations, which denotes population 
asymmetry as a robust mechanism of tissue regeneration in all permanent compartments of 
the epidermis. 
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3.3 PAPER III 
Healthy skin harbours pre-existing micro-niches that promote tumour 
formation 
It is increasingly recognized that the tumour microenvironment has a profound influence on 
the growth of a tumour [110]. Cancer-associated fibroblasts, inflammatory cells, endothelial 
cells, and many other cell types jointly create a milieu for solid cancer cells to thrive. Hence, 
we asked if such external factors also govern tumour development at the early tumour-
initiation stage. Having characterized the stem cell dynamics of Lgr6+ cells during 
homeostasis, we employed this model to target epidermal progenitor cells in various 
epithelial compartments (isthmus, SG, IFE, bulge) that are subjected to distinct 
environmental cues. Activation of the Hh pathway enabled us to study whether any of these 
compartments is more susceptible to BCC development than the others and what are the 
underlying differences that cause this diversity. 
To induce BCC formation in mice, we generated Lgr6Cre/Tomato/Ptch1fl/fl mice, in which 
the expression of Ptch1 is abrogated upon Cre recombination. Initiating simultaneous lineage 
tracing and Ptch1 knockout in Lgr6+ cells of adult mice, we observed rapid development of 
lesions, resembling early BCCs. These lesions, however, prevailed at the lower isthmus 
region. The response of IFE cells to Hh pathway activation was much less pronounced and 
SG cells did not react during the observation period. Strikingly, we found large IFE lesions 
that appeared in a regular pattern, progressing at a similar rate as the isthmus tumours. To 
validate Lgr6+ IFE cells as a possible source for these rare lesions, we induced BCCs by 
ectopic expression of GLI1, which activates Hh signalling more strongly than Ptch1 deletion, 
and simultaneously traced Lgr6+ cells. Continuous expression of GLI1 in all basal cells 
indeed led to the rapid appearance of BCC-like lesions in the IFE, which originated from 
Lgr6-positive and -negative cells. This shows that Lgr6+ IFE cells have the capacity to initiate 
IFE tumours. 
But why are only a few of them susceptible to mild activation of Hh signalling? Examining 
the niche composition and factors influencing gene expression in the isthmus, we 
hypothesised that the cutaneous nerve fibres, which provide Hh ligand to the lower isthmus, 
may be a dominant external factor promoting BCC emergence in the HF. When inspecting 
Gli1 expression, which indicates active Hh signalling, in the IFE, we found that Gli1 is 
indeed expressed by a rare subset of IFE epithelial cells and adjacent mesenchymal cells, 
alike the isthmus niche. These Gli1+ IFE cells localize to specialized touch perception 
structures, called touch domes, which harbour nerve fibre endings connected to 
neuroendocrine Merkel cells. Moreover, Lgr6+/Gli1+ cells were detected within touch domes, 
accounting for another similarity to the isthmus niche, where Lgr6+/Gli1+ cells are also 
present. 
To provide further evidence that Lgr6+/Gli1+ touch dome IFE cells are able to generate BCC-
like lesions in the IFE we generated Gli1Cre/Tomato/Ptchfl/fl mice. Upon tamoxifen 
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administration, these mice developed large Merkel cell-associated tumours within the IFE, 
confirming that touch dome cells are founders of BCC. To substantiate that also in the Lgr6 
model IFE tumours predominantly arise from Lgr6+ touch dome cells, we analysed the 
presence of Merkel cells around the IFE lesions in Lgr6Cre/Tomato/Ptchfl/fl mice. BCC-like 
lesions that were associated with Merkel cells were significantly larger than tumours in the 
remaining IFE. This collectively indicates that the isthmus and the touch dome niche promote 
BCC initiation and progression. Epithelial cells within both niches are influenced by extrinsic 
nerve signals, which facilitate a constitutive activation of the Hh pathway, thereby lowering 
the threshold for BCC growth. 
Remarkably, the isthmus and touch dome niche do not only resemble each other by the 
presence of nerve fibres and active Hh signalling. We found several additional genes that are 
expressed in both niches, e.g. extracellular matrix protein versican and transcription factor 
Sox9. Intriguingly, many of those genes have been associated with BCC in mouse models and 
human BCC. This suggests that there are pre-existing micro-niches within the skin that 
predispose to BCC development by inducing the expression of BCC-related genes. 
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4 GENERAL DISCUSSION AND PERSPECTIVES 
 
4.1 SIGNIFICANCE AND DISCUSSION OF THE WORK 
 
The main goal of this thesis was to study the behaviour of epidermal stem cells under 
different conditions, and to get insights into the capabilities and flexibility of stem cells 
within different niches of the epidermis. The marker genes Lgr5 and Lgr6 allowed targeting 
cells within different locations of the skin so that the individual potential of those subsets 
could be determined. The work presented in this thesis reinforces the enormous plasticity of 
epidermal cells, demonstrated by their involvement in wound healing, their distinct 
compartmental contributions during homeostasis as well as their tumour initiation potential.  
Although many experiments had been conducted in previous research to identify and 
characterise numerous different stem cell populations in mouse skin [168,169], several 
important questions regarding the homeostasis of the epidermis remained. How are the 
separate parts of the epidermis precisely maintained and how are the different stem cell 
populations coordinated? To better understand the interactions between cell populations in 
the HF and the IFE, we performed lineage tracing of Lgr6+ keratinocytes during tissue 
homeostasis in Paper II. An important prerequisite for these experiments was to accurately 
determine the expression pattern of the marker gene and test the floxed reporter expression 
with Lgr6Cre as a driver (which turned out to be highly distinct for the different reporter 
alleles, see Paper III). The results of the Confetti lineage tracing signified that the targeted 
Lgr6+ basal cells exhibit self-renewal potential irrespective of their location within the 
different epidermal compartments. Moreover, the three main Lgr6+ populations in the 
isthmus, SG, and IFE were largely independent of each other, maintaining predominantly 
their respective compartment. These findings match other predictions that the progeny of 
stem cell populations in the permanent part of the HF do not cross compartment boundaries 
[35,170]. The concept of tissue compartmentalisation maintains that compartments are 
delimited by tightly regulated boundaries that prevent stem cell progeny from leaving their 
home territory [171]. Stem cell compartmentalisation is also found in organs with a less 
distinct morphological demarcation of the compartments as in the HF, such as the mammary 
gland [172], the prostate [173] and the Drosophila midgut [174,175]. However, it is still not 
fully clear how these compartment borders are established. 
Moreover, our results imply that there is no inherent hierarchy between the progenitors within 
different locations, even though they follow distinct differentiation pathways, e.g. stratified 
epidermis in the IFE, sebocyte maturation in the SG, and differentiation in the isthmus 
without formation of a granular layer [176]. The fact that the dynamics of the clone 
expansion over time was very similar in the three compartments, overall matching the 
predictions of the committed progenitor model, suggests that the stem cell populations are 
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equipotent rather than following a hierarchy or being subject to non-neutral drift. However, 
this assumption must be substantiated with more precise data, which allow the determination 
of the modelling parameters, such as stem cell division rate and stem cell fraction [64]. Only 
if the parameters of the stochastic model are concordant for the three populations, equal 
potency can be inferred. Several examples have shown that a proliferation bias between two 
populations undergoing population asymmetry, e.g. by introduction of tumourigenic 
mutations leading to dominant expansion of clones, is reflected in altered stem cell division 
rate and stem cell fraction [177-179]. Another recent observation supports equal intrinsic 
potency of all basal HF cells. Cells from the upper HF compartments were able to replace 
bulge cells after laser ablation and adopted a bulge cell fate in the new niche [31]. This also 
highlights that the location seems to be the major determining factor for the different 
differentiation paths in the epidermal compartments. 
One drawback of cell population-based lineage-tracing experiments is the fact that the fate of 
an individual stem cell cannot be tracked directly. Hence, correlations between the exact 
position in the tissue and the associated fate outcome are hard to draw, if not impossible. 
However, these questions are highly interesting, e.g. if there is a pre-defined hierarchy in the 
telogen bulge, determining which cells will generate each layer of the IRS and ORS in the 
next anagen cycle, respectively. Using intra-vital fluorescent imaging, the group of Valentina 
Greco has now started to illuminate single-cell contributions during anagen induction and 
catagen, and correlated positional cues to a particular fate outcome [31,180,181]. 
In Paper I, we have shown that wounding and tumour induction can profoundly change the 
behaviour of cells compared to homeostasis, and how wounding and tumour development act 
together to alter the cell fate. The discovery that bulge and hair germ cells can preserve 
tumour-initiating mutations and transfer them to another epidermal compartment offers an 
intriguing explanation of how a wound environment accelerates BCC development. 
Expression of full-length GLI1 in K5-positive basal keratinocytes demonstrated that BCC can 
also develop from IFE cells, and not only from HF cells, even though BCC cells have a 
similar phenotype to HF cells and BCC initiation resembles HF morphogenesis [139,140]. 
This finding was confirmed by several publications, using other genetic models, e.g. 
expression of constitutively active Smo under the K5 promoter and expression of a GLI2 
activator form (GLI2ΔN) in various epidermal compartments [28,126]. Similar to Hh 
activation the wound response also seems to re-program the cells into a developmental-like 
state [89]. The regeneration process relies on stimulating the same pathways and fate-switch 
mechanisms to restore tissue function that are also active during HF morphogenesis, which is 
reflected in its extreme case by de novo HF induction in large wounds [106,108,109]. Hence, 
when ectopic Hh coincides with a chronic wound environment the factors promoting BCC 
are potentiated and might thus result in accelerated cancer formation. 
In Paper III, we have deepened the understanding of which epidermal populations are most 
susceptible to tumour formation and which factors play a role. As was shown in Paper I, 
almost all basal keratinocytes are able to initiate BCC formation in response to augmented Hh 
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signalling, albeit with varying sensitivity [182]. This became most apparent when Ptch1 
knockout was driven by the broadly expressed promoters of Krt5 and Lgr6. Thus, it is 
interesting to compare the dynamics of BCC development in Lgr5Cre/Ptchfl/fl and 
Lgr6Cre/Ptchfl/fl mice to identify the differences between individual epidermal stem cell 
populations. It is difficult to compare results obtained in different studies using diverse mouse 
models and types of Cre activation, but in this case the same genetic modifications were 
introduced and the same protocols were followed. Overall, tumours were formed significantly 
faster by Lgr6+ isthmus cells, which responded within days, compared to Lgr5+ bulge/hair 
germs cells, which took months to grow into advanced lesions. This discrepancy evidently 
highlights that the niche factors have a profound effect in adjusting the sensitivity of cells to 
becoming tumour-initiating cells. 
The results presented in Paper III support the concept of pre-existing micro-niches in healthy 
tissue that predispose for tumour development by providing a tumour-like microenvironment 
for early transformed (cancer-initiating) cells. It is more and more recognised that the 
microenvironment of a cancer plays a decisive role in promoting tumour growth and 
progression [183,184]. Examples of non-transformed cells that support tumour growth are 
fibroblasts in contact with the epithelial cancer cells that produce growth factors, or 
endothelial and immune cells that are recruited by signals from the tumour and promote 
blood vessel sprouting. Our study expands this concept to the pre-tumour stage by attributing 
cancer-promoting properties to the microenvironment of healthy epithelium. 
The key finding that the nerve-proximal niches, isthmus and touch dome, promote BCC 
formation was confirmed in a simultaneous study using various other Cre drivers [185]. 
Furthermore, this study presented evidence that de-nervation reduces Ptch1 knockout-driven 
tumour development in the touch dome, indicating that nerve-derived factors contribute to the 
cells’ enhanced sensitivity to transformation. 
The observations in Paper III that Gli1-expressing keratinocytes are most susceptible to 
ectopic Hh and BCC formation, may appear contradictory to the fact that Gli1 is also 
expressed in the hair germ of telogen HFs [34] and should overlap with Lgr5 expression. Yet 
Lgr5Cre/Ptchfl/fl cells were much less responsive than the Gli1Cre/Ptchfl/fl populations in 
other parts of the epidermis (see Paper I). Cells in the isthmus and touch dome are normally 
not primed to generate cells of the hair lineage but follow differentiation into stratified 
epidermis. Generalising these observations, basal cells of the epidermal lineage seem to be 
more prone to develop BCC than cells participating in hair regeneration. It could thus be 
speculated that Gli1+ hair germ cells may already have a machinery in place that is adapted to 
control fluctuating Hh signals in the context of the hair cycle. Therefore, these cells might be 
less sensitive to enhanced Hh and do not quickly transform into cancer cells. 
The general concept supported by all three studies tracing Lgr5- and Lgr6-expressing 
epidermal stem cells is that basal cells in the different epidermal compartments have their 
specific function during homeostasis without conforming to a hierarchy. Moreover, they 
demonstrate a high plasticity in switching fates in response to perturbations. In summary, the 
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results highlight the influence of environmental factors on tissue stem cell behaviour, which 
can determine cellular properties, such as susceptibility to tumourigenic transformation, and 
contribution to wound healing. 
 
 
4.2 IMPLICATIONS FOR FUTURE RESEARCH 
 
4.2.1 Interactions between Lgr5+ and Lgr6+ cell populations 
Lineage tracing performed by different groups are difficult to compare due the variations in 
the methodology. Especially, different transgenic mouse models to induce Cre recombination 
or direct reporter expression, different tracing protocols, and non-standardised analysis 
methods, result in significant variation between individual studies. Therefore, the interactions 
between the multitude of HF stem cell lineages marked by distinct genes have remained 
unclear. The results of the studies presented here support that during homeostasis the progeny 
of distinct stem cell populations do not mix significantly. This implicates a 
compartmentalisation of the different parts of the HF, with borders being maintained between 
the compartments. 
Despite the same genetic strategy and lineage tracing protocols, comparing the lineage tracing 
patters between Lgr5Cre and Lgr6Cre mice is still not trivial because the progeny of the two 
populations cannot be labelled and discriminated simultaneously. Nevertheless, it seems that 
during the telogen phase there is only minimal cellular interchange between the bulge and the 
isthmus, insinuating a border between the two compartments. Lgr5+ cells do not frequently 
trace into the isthmus and likewise contribution of Lgr6+ progeny to the bulge was only 
detected towards very long tracing periods (~1 year). In a similar fashion, it was observed 
that HF infundibulum cells do not trace into the IFE during homeostasis, maintaining a 
similar “invisible border” [58,59]. 
Future studies, potentially involving alternative recombination strategies (e.g. combining 
Cre/LoxP with Flp/FRT recombination to label two individual populations simultaneously), 
will be necessary to resolve the exchange between compartments and discover the factors that 
define the borders in the epidermis. In the case of the bulge-isthmus border, extrinsic signals 
may play a role in specifying the cellular border, e.g. the interactions with nerve fibres and 
NCPCs, the arrector pili muscle, or the presence of the inner bulge cells may modify the cell 
behaviour [186]. Moreover, the properties of the cells in the isthmus and bulge are 
intrinsically distinct; bulge cells are quiescent and have large nuclei whereas isthmus basal 
cells are mitotically active and have a small cell size. These inherent differences may also act 
in preventing a mixing of the cell lineages. Additionally, cell-cell interactions are guided by 
surface receptor expression such as ephrin receptors, which are associated with boundary 
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formation [187]. Ephrins and their receptors are present in the epidermis, and thus are a 
potential subject for further research [188]. 
 
4.2.2 Regulation of Lgr6 expression 
The gene expression analysis of Lgr6-expressing keratinocytes presented in Paper II aimed 
at expanding the knowledge about the regulation of Lgr6 expression in skin and what 
discriminates Lgr6-expressing cells from Lgr6-negative cells. On the global level, combining 
cells from all the different sampled compartments, there was no significantly enriched gene 
signature or pathway, which was specifically correlated with Lgr6. This implies that Lgr6 
gene regulation is context dependent; in each niche different signals might be able to activate 
the gene expression. In support of this hypothesis, different studies reported Lgr6 up-
regulation in response to various conditions: dominant negative LEF1 expression in K15-
positive bulge cells [56], Wnt3a stimulation of bulge cells [189] and overexpression of Stat3c 
in basal cells [190]. Conversely, β-catenin knockout [189] and splicing factor SRSF6 induced 
Lgr6 down-regulation [191]. 
A study by Liao and Ngyen in 2014 proposed that Lgr6 expression, similarly to Gli1 
expression, is established by signals arising from proximal nerve fibres, based on the 
observation that de-nervated skin did not exhibit Lgr6 reporter expression [79]. Led by the 
assumption that Lgr6 expression in the HF and IFE may be governed by extrinsic signals 
from the microenvironment such as cutaneous nerve endings, we conducted a preliminary 
study to analyse the dynamics of Lgr6 expression in the IFE. Strikingly, short-term lineage 
tracing, after labelling almost all Lgr6+ cells with permanent Tomato expression, revealed 
that Lgr6 expression seems to be an invariable state of certain IFE cells and is not fluctuating 
between different cells. The small, unlabelled fraction of Lgr6+ cells did not increase over 
time, which would have been expected if Lgr6 expression was turned on in unlabelled Lgr6-
negative cells during the tracing period (Füllgrabe and Kasper, unpublished). Thus, Lgr6 
expression is probably not a stochastic event but more likely a permanent state that is 
maintained in certain cells. To confirm that peripheral nerves induce Lgr6 expression, these 
results must be substantiated by further research, additionally assessing the co-localisation of 
Lgr6+ cells with nerve endings protruding into the IFE. 
 
4.2.3 Function of the LGR6 receptor in the skin 
A yet unanswered question of tremendous interest is the function of the LGR6 receptor and 
its role in keratinocytes. It has been claimed that LGR6 acts similarly to LGR4 and LGR5 as 
an R-spondin receptor, enhancing canonical Wnt signalling [82,84-86]. However, convincing 
experimental data is lacking. Only one study presented results that attest human LGR6 a 
certain R-spondin binding affinity [192]. Nevertheless, the downstream functional effect of 
this interaction remains elusive [193]. It may be possible that LGR6 instead mediates 
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suppression of Wnt signals by acting as an R-spondin decoy receptor. The partial overlap of 
the Lgr6 and Lgr4/5 expression patterns in murine epidermis [33] could be an indication that 
LGR6 may sequester R-spondins and prevent their binding to LGR4 and LGR5 as part of a 
negative feedback loop. LGR6 would thereby aid in establishing an activity gradient of the 
Wnt signals between the bulge (active Wnt), and the upper part of the HF and the SG 
(suppressed Wnt). 
In order to gain further insights into the role of the LGR6 receptor in the murine skin, we 
assessed the phenotype of Lgr6 knock-in mice in more detail. In a preliminary study, we 
analysed gene expression of keratinocytes from homozygous Lgr6Cre mice, in which the 
knock-in cassette should abrogate transcription of the Lgr6 gene, starting at the first exon. 
Comparing homozygous Lgr6Cre cells to heterozygous or wild type cells by microarray 
analysis revealed a general two-fold down-regulation of Lgr6 expression, indicating that Lgr6 
transcription is not completely suppressed in these mice (Füllgrabe and Kasper, unpublished). 
This partial knockout may be due to alternative transcriptional start sites further downstream 
in the gene locus. This was substantiated by real-time PCR analysis, showing that transcripts 
of Lgr6 from exon 4 are present in homozygous mice, which were thus not influenced by the 
presence of the knock-in cassette. However, it is unclear whether these transcripts are 
translated into proteins and if the potential N-terminally truncated version of the receptor 
exerts a different function as the full-length version. On the global level, homozygous 
Lgr6Cre keratinocytes showed increased transcription of a significantly enriched cluster of 
olfactory receptors. Down-regulated genes were associated with lipid synthesis, pointing 
towards a co-regulation of Lgr6 expression with SG-specific genes and thus a role of Lgr6 
within sebocytes. The correlation of Lgr6 reduction with the increased expression of olfactory 
receptors seems odd and further experiments are needed to validate these results. 
Remarkably, Lgr6 is highly expressed in the olfactory brain of adult C57BL/6 mice 
(Expression Atlas/ArrayExpress accession E-MTAB-3579) [194,195]. Moreover, Lgr6 
expression was found in taste bud stem cells and in cells of the developing mouse cochlea in 
two very recent studies [196,197]. This insinuates a general association of Lgr6 with sensory 
perception. 
 
4.2.4 Regulation of stem cell renewal 
The recent discoveries deciphering the stochastic nature of stem cell divisions have 
challenged old paradigms of stem cell biology and opened up new theories. The results 
presented in Paper II deepen the understanding of epithelial tissue renewal in adult 
organisms. The actively proliferating epidermal regions such as the upper HF compartments, 
the SG, and the IFE, all show the same pattern of stem cell renewal. This behaviour is also 
inherent to many other rapidly renewing epithelia throughout the whole body [198]. The high 
conservation of this process demonstrates its significance. However, the mathematical 
modelling only describes the behaviour of the cells we can measure, it does not expose the 
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underlying cause of the cell division outcome. So how is stochastic stem cell division 
regulated molecularly? 
The view that there is a dedicated set of stem cells within a certain tissue, marked by a 
specific gene expression signature, does not seem to hold true [199]. The current models of 
stochastic stem cell renewal seem to be in line with the conception that all basal cells have the 
same intrinsic potential to be long-lived and thus all basal cells could be considered as stem 
cells. But at the same time this means that all basal cells also have the same likelihood to 
terminally differentiate. 
The question remains if there are marker genes that correlate with a pre-determined fate 
outcome already before cell division is taking place. To find out if we really can distinguish 
between the three kinds of cell divisions, we would need to make use of sophisticated live-
fate tracking of single-cells [31,181,200]. Combining live imaging in vivo or in vitro with 
fluorescent gene-expression reporters would enable testing if certain genes are specifically 
expressed in cells that choose a certain fate after division, e.g. a gene that is only expressed in 
those 10% of basal cells that are about to undergo symmetrical division, yielding two stem 
cells. This method would also yield some clues whether the position of a certain cell and its 
microenvironment play decisive roles in this decision. 
Without marker genes or any other indication that there is indeed a difference between basal 
cells with a specific fate outcome or differentiation status, it is not sensible to distinguish 
stem cells based on fate outcome because the fate cannot be determined at the stage of the 
cell division. At this stage it is difficult to define what is a stem cell at all. Cells that would 
normally undergo differentiation can even turn back and change fate to regain stem cell 
capacity in response to injury or stress, and thus the cells may retain their stem cell potential 
all the time [199]. 
Another concept of how stem cell division and self-renewal might be regulated in the 
epidermis is an entirely self-organising system. Nothing is pre-determined and stem cells 
divide as long as there is space. If cells lose their contact with the basement membrane 
because they are pushed upwards after division, the differentiation programme is induced. 
When basal cell density becomes higher, the cells pause replicating. Research on the effect of 
mechanical forces on cells and their gene expression has already effectively shown that the 
physical environment alone can have a major impact on the activated pathways [45,201]. 
Moreover, certain pathways have been identified that are regulated by physical signals and 
can transmit these stimuli to the nucleus, such as the Hippo pathway and Yap/Taz 
transcription regulators as key mechanotransducers [202-204]. Again interactions between 
cells and the extracellular matrix as well as cell-cell interactions are central for signal 
transduction in such a system. This is a compelling theory because of its simplicity, offering 
much potential for future research. 
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4.2.5 Wound healing and tumourigenesis 
Some questions also remain unanswered regarding the response of epidermal stem cells to 
wound healing. HF stem cells migrate to the IFE during wound repair and become integrated 
as IFE stem cells. But it is unknown what signals activate stem cell migration from the HF to 
the IFE, how these signals are mediated and how the response changes the transcription of the 
keratinocytes. Different keratinocyte populations might react differently to these stimuli, as 
they also show differing properties such as survival time within the newly formed scar 
epidermis [27,34,35,102]. 
Also the molecular response of early transformed keratinocytes is not fully understood yet. 
Deciphering the transcriptional signatures of transformed epidermal cells within different 
niches might help to understand the dynamics of cells in different locations in the HF. Why 
do some populations remain dormant whereas others quickly form lesions when challenged 
with the same mutation? 
Finally, comparing the transcriptional changes during early tumourigenic transformation to 
those occurring in normal stem cells that are activated by wound healing may uncover a set of 
genes that is associated with the re-epithelialisation response but is not involved in cancer 
development. Those genes can potentially be harnessed to safely stimulate epidermal stem 
cells in order to improve healing of chronic wounds. A better understanding of the signalling 
mechanism and the transcriptional changes that occur during the “natural reprogramming” of 
epithelial stem cells will also advance ex vivo skin reconstruction, and gene-based therapy of 
chronic wounds and other skin diseases [89]. 
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